Refined sugars and simple carbohydrates White sugar, table sugar, cane sugar, high-fructose corn syrup Syrups (maple syrup, agave, molasses) in large amounts Sweets, candies, baked goods Sugary beverages (sodas, sweetened teas, juice concentrates) Candida uses glucose, fructose, and other sugars as its energy sources
Dual GLP-1/Glucose-Dependent Insulinotropic Peptide (GIP) Receptor Agonists (Dual GLP-1/GIPR Agonists, DA) Currently, novel dual GLP-1/GIP receptor agonists have been developed (55), which are derived from an intermixed sequence of GLP-1 and GIP and have proved properties enhancing efficacy of insulinotropic and antihyperglycemic compared with selective GLP-1 receptor agonists such as liraglutide
This precision minimizes variability and helps isolate the compound's specific effects
NAC remains effective regardless because it directly increases intracellular glutathione synthesis rather than relying on dietary intake
Long-term considerations Because these drugs are so new, there are a lot of long-term considerations we dont have solid answers for yet